Transthyretin (ATTR) Amyloidosis
View the latest scientific data presented at congress events in the past 2 years and discover peer-reviewed publications related to ATTR Amyloidosis.
The information on this page pertains to select congress and publication resources. It is not intended to serve as a comprehensive list of all congress and publications resources.
Publications
Transthyretin Amyloidosis (ATTR)
Impact of Vutrisiran on Quality of Life and Physical Function in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy
Neurology and Therapy
Transthyretin Amyloidosis (ATTR)
Indirect treatment comparison (ITC) of the efficacy of vutrisiran and tafamidis for hereditary transthyretin-mediated amyloidosis with polyneuropathy
Expert Opinion on Pharmacotherapy
Transthyretin Amyloidosis (ATTR)
Effect of patisiran on stroke volume in hereditary transthyretin-mediated amyloidosis: insights from pressure–volume analysis of the APOLLO study
European Journal of Heart Failure
Transthyretin Amyloidosis (ATTR)
Impact of baseline polyneuropathy severity on patisiran treatment outcomes in the APOLLO trial
Amyloid
Transthyretin Amyloidosis (ATTR)
Gene Silencing Therapeutics in Cardiology: A Review Article
International Journal of Cardiovascular Sciences
Transthyretin Amyloidosis (ATTR)
Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial
Amyloid
